Claudio Todisco
Associate
Elisa Stefanini and Claudio Todisco impress with their regulatory expertise, commercial approach and sector understanding.“
Claudio joined Portolano Cavallo in 2022.
He assists both Italian and foreign clients in the Life Sciences-Healthcare sector, dealing primarily with pharmaceutical and medical device law.
Claudio is ranked as“Leading associate“ by the Legal 500 EMEA 2025 for the “Healthcare and Life Sciences” area.
Claudio earned his Law degree from the Università degli Studi di Pavia in 2015 and then graduated from the Postgraduate School of Legal Professions at the Università Cattolica del Sacro Cuore in Milan.
Before joining the firm, he worked with other leading Italian law firms, gaining experience in the areas of civil and administrative law, with particular focus to the pharmaceutical sector.
Languages: English
He is a member of the Milan Bar Association (45577).
Latest articles
-
25 September 2024New Aifa guidelines on observational studies and decentralized clinical trials: digital tools increasingly in focus
-
23 September 2024New Aifa guidelines on clinical trials between simplification and decentralization
-
16 September 2024PAD, how to certify digital procurement platforms
-
9 July 2024Transparency in clinical trials: Revised transparency rules take effect
